← Back to Search

Not Applicable

Acupuncture for Cancer-Related Cognitive Impairment

Phase 2
Waitlist Available
Led By Jun Mao, MD, MSCE
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older
Diagnosis of breast, colorectal, prostate, or gynecological cancer
Must not have
Active disease
Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other organic brain disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks

Summary

This trial is exploring whether acupuncture can help improve cognitive difficulties in cancer patients by stimulating the body to heal itself.

Who is the study for?
This trial is for English-speaking adults over 18 who've finished initial cancer treatment at least a month ago and feel their memory or concentration has worsened since their diagnosis. They must not have active disease, recent acupuncture for cognition, certain psychiatric disorders, dementia, Parkinson's, or recent medication changes.
What is being tested?
The study tests if acupuncture can help with cognitive issues in cancer patients. Participants will be randomly assigned to receive either real acupuncture or sham (placebo) acupuncture. There's also an option of a waiting period followed by optional acupuncture.
What are the potential side effects?
Acupuncture may cause minor side effects like soreness or bruising at needle sites, fatigue, headache, and feeling dizzy during the session. Sham acupuncture involves non-penetrating needles which should have minimal to no side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with breast, colorectal, prostate, or gynecological cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My disease is currently active.
Select...
I have been diagnosed with a brain disorder such as Alzheimer's or Parkinson's.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cognitive difficulties as measured by the Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog)

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Wait-List ControlExperimental Treatment1 Intervention
This arm is Closed to accrual.
Group II: AcupunctureExperimental Treatment1 Intervention
Group III: Sham Acupuncture (SA)Placebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,976 Previous Clinical Trials
599,452 Total Patients Enrolled
208 Trials studying Breast Cancer
82,963 Patients Enrolled for Breast Cancer
Jun Mao, MD, MSCEPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
9 Previous Clinical Trials
2,022 Total Patients Enrolled
1 Trials studying Breast Cancer
270 Patients Enrolled for Breast Cancer

Media Library

Acupuncture (Not Applicable) Clinical Trial Eligibility Overview. Trial Name: NCT04007770 — Phase 2
Acupuncture (Not Applicable) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04007770 — Phase 2
~4 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top